TPG-backed Aptalis files for IPO of up to $500 million

BRIDGEWATER, N.J. (Reuters)—Specialty drugmaker Aptalis Holdings Inc., owned by private equity firm TPG Capital LP, filed with U.S. regulators to raise up to $500 million in an initial public offering of its common stock. Goldman Sachs, J.P. Morgan, ...